AVEO Pharmaceuticals Inc (AVEO) Insider Trading
- $27,540,635.86
- $2,800,274.50
- Sept. 1, 2021
- Equity Opportunities Iv Growth
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Sept. 1, 2021 | CEO | 15,000 | $6.48 | Buy | $97,200.00 | |
| Aug. 10, 2021 | Insider | 2,608 | $5.75 | Buy | $14,996.00 | |
| June 19, 2020 | Major Shareholder | 1,428,571 | $5.25 | Buy | $7,499,997.75 | |
| Nov. 21, 2019 | CEO | 150,000 | $0.60 | Buy | $90,000.00 | |
| April 8, 2019 | Major Shareholder | 4,347,827 | $1.14 | Buy | $4,956,522.78 | |
| Dec. 21, 2018 | Major Shareholder | 500,000 | $1.55 | Buy | $775,000.00 | |
| Dec. 10, 2018 | Major Shareholder | 170,400 | $1.99 | Buy | $339,096.00 | |
| Dec. 6, 2018 | Major Shareholder | 27,300 | $1.99 | Buy | $54,327.00 | |
| Nov. 30, 2018 | Major Shareholder | 96,400 | $1.98 | Buy | $190,872.00 | |
| Nov. 28, 2018 | Major Shareholder | 24,500 | $1.99 | Buy | $48,755.00 | |
| Nov. 21, 2018 | Director | 109 | $2.05 | Buy | $223.45 | |
| Nov. 19, 2018 | Major Shareholder | 1,200,000 | $1.86 | Buy | $2,232,000.00 | |
| Nov. 16, 2018 | Director | 1,147,068 | $1.87 | Sell | $2,145,017.16 | |
| Nov. 15, 2018 | Major Shareholder | 340,000 | $1.86 | Buy | $632,400.00 | |
| Nov. 14, 2018 | Director | 325,139 | $1.90 | Sell | $617,764.10 | |
| Aug. 21, 2018 | Major Shareholder | 663,716 | $2.26 | Buy | $1,499,998.16 | |
| July 19, 2018 | Major Shareholder | 250,600 | $1.96 | Buy | $491,176.00 | |
| June 27, 2018 | Major Shareholder | 5,295 | $2.15 | Buy | $11,384.25 | |
| May 30, 2018 | Major Shareholder | 275 | $2.15 | Buy | $591.25 | |
| May 21, 2018 | Major Shareholder | 236,479 | $2.13 | Buy | $503,700.27 | |
| May 17, 2018 | Major Shareholder | 184,179 | $2.13 | Buy | $392,301.27 | |
| May 8, 2018 | Major Shareholder | 70,873 | $2.13 | Buy | $150,959.49 | |
| April 10, 2018 | Major Shareholder | 920,976 | $2.30 | Buy | $2,118,244.80 | |
| April 6, 2018 | Major Shareholder | 685,676 | $2.24 | Buy | $1,535,914.24 | |
| March 28, 2017 | Major Shareholder | 6,000,000 | $0.50 | Buy | $3,000,000.00 | |
| Jan. 16, 2015 | VP | 3,075 | $0.82 | Sell | $2,521.50 | |
| Jan. 7, 2015 | CEO | 4,484 | $0.80 | Sell | $3,587.20 | |
| Jan. 30, 2014 | SVP | 5,430 | $1.64 | Sell | $8,905.20 | |
| March 14, 2013 | CFO | 1,061 | $7.34 | Sell | $7,787.74 | |
| March 7, 2013 | Director | 55,499 | $6.73 | Buy | $373,508.27 | |
| Dec. 13, 2012 | CEO | 75,000 | $6.65 | Buy | $498,750.00 | |
| Dec. 13, 2012 | Director | 2,371 | $6.78 | Buy | $16,075.38 | |
| Dec. 3, 2012 | Director | 1,250 | $6.41 | Buy | $8,012.50 | |
| Sept. 13, 2012 | CFO | 1,386 | $10.60 | Sell | $14,691.60 | |
| Aug. 8, 2012 | Director | 1,000 | $8.63 | Buy | $8,630.00 |
Insiders are both buying and selling AVEO Pharmaceuticals Inc stock.
The insider traders at AVEO Pharmaceuticals Inc are: Equity Opportunities Iv Growth, Peter W Sonsini, Peter J Barris, Ravi Viswanathan, Robert C Young, Michael P Bailey, Anthony B. Evnin, David Brannon Johnston, Matthew D Dallas, Equity Opportunities Fu Growth, Henri A Termeer, Joseph Vittiglio, Anthony B Evnin, Michael Ferraresso, and Ngoc Tuan Ha
The most active insider trader at AVEO Pharmaceuticals Inc is Equity Opportunities Iv Growth with 8 trades.
Anthony B. Evnin has sold the most AVEO Pharmaceuticals Inc stock with a total value of $4,907,798.42.
Peter W Sonsini has bought the most AVEO Pharmaceuticals Inc stock with a total value of $15,735,477.50.
The most recent insider trade for AVEO Pharmaceuticals Inc was on Sept. 1, 2021.
The single biggest insider buy for AVEO Pharmaceuticals Inc was from Peter W Sonsini with a total value of $7,499,997.75 on June 19, 2020.
The single biggest insider sell for AVEO Pharmaceuticals Inc was from Anthony B. Evnin with a total value of $2,145,017.16 on Nov. 16, 2018.